Myocardial Inflammation Clinical Trial
Official title:
Outcome of Myocardial Inflammation After Steroid Therapy in Thai Systemic Sclerosis Patients: an Open Label Study
Primary myocardial involvement is common in scleroderma, effected to pericardium, vascular, conducting defect and especially myocardium. Cardiac MRI is widely used for assessment of cardiac involvement in scleroderma, both structural and functional pathology. Cardiac MRI has a diagnostic accuracy of 85% for the detection of myocardial inflammation. Nowadays, the treatment of myocardial inflammation in scleroderma is uncertain. The investigator's study aims to define the cardiac outcome after moderate dose steroid therapy in the patients who have myocardial inflammation detection by cardiac MRI.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04322630 -
Mer-TK in Human Cardiac Cells
|
||
| Completed |
NCT03776682 -
Myocardial Inflammation in Rheumatoid Arthritis: A Descriptive Study
|
||
| Completed |
NCT04940650 -
COUREUR Study Myocardial Inflammation in Cyclist Part 1
|
N/A | |
| Terminated |
NCT03619876 -
Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
|
Phase 4 | |
| Completed |
NCT05138003 -
COUREUR Study Myocardial Inflammation in Cyclist Part 2
|
N/A | |
| Completed |
NCT03782259 -
Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2
|
Phase 4 | |
| Recruiting |
NCT03525639 -
CMR Evaluation of Myocardial Inflammation Persistence After Acute Myocarditis: Prognostic Relevance
|
N/A | |
| Terminated |
NCT03103490 -
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation
|
Phase 2 | |
| Completed |
NCT04437927 -
Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT
|
||
| Recruiting |
NCT05519735 -
Lymphatic Organs and Myocardium After Myocardial Infarction
|
N/A |